Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Hormone Receptor Positive HER-2 Negative Breast Cancer
Augsburg, Bavaria
Hormone Receptor Positive HER-2 Negative Breast Cancer Clinical Trials in Augsburg, Bavaria
1 recruiting
Augsburg, Bavaria, Germany
Showing
1–1
of
1
trials
Recruiting
Phase 2
Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
Advanced or Metastatic Breast Cancer
BRCA1 Mutation
BRCA2 Mutation
+1 more
GBG Forschungs GmbH
176 enrolled
36 locations
NCT06201234
Feedback